drugset / Trial / NCT05265507
Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron
Phase 4
Unknown
480 enrolled
The Second Affiliated Hospital of Chongqing Medical University
CHONGQING BANAN HOSPITAL OF TCM · collabChongGang General Hospital · collabChongqing Liangping District People's Hospital · collabChongqing Medical Center for Women and Children · collabChongqing Medical University · collabChongqing Public Health Medical Center · collabChongqing University Jiangjin Hospital · collabChongqing Yongchuan District People's Hospital · collabDianjiang People's Hospital of Chongqing · collabJiulongpo People's Hospital of chongqing · collabPeople's Hospital of Pengshui County · collabThe First People's Hospital Of Chongqing Liang Jiang New Area · collabThe Ninth People's Hospital of Chongqing · collabThe People's Hospital of DAZU ，Chongqing · collabThe People's Hospital of Nanchuan · collabThe People's Hospital of Qijiang District，Chongqing · collabThe People's Hospital of Tongliang District， Chongqing city · collabThe People's Hospital of Yubei District of Chongqing city · collabUniversity-Town Hospital of Chongqing Medical University · collabWest China Hospital · collabXiangya Hospital of Central South University · collabYunyang people's Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To compare the anti-nausea and vomiting effect between glycopyrronium and ondansetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to explore the feasibility of using glycopyrronium to prevent postoperative nausea and vomiting.
Timeline
- Start
- 2022-03-21
- Primary completion
- 2023-05-30
- Completion
- 2023-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 0.2 mg | Intravenous |
| Comparator | Ondansetron | Other / unclassified | 4 mg | Intravenous |
Indications
No indication recorded.